Tuhura Biosciences Inc. (HURA) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tuhura Biosciences Inc. (HURA:NASDAQ), powered by AI.

Current Price
$2.23
P/E Ratio
-3.6
Market Cap
107M
Sector
Healthcare
What is the Tuhura Biosciences Inc. stock price forecast?

Tuhura Biosciences Inc. is currently trading at $2.23. View real-time AI analysis on Alpha Lenz.

What is Tuhura Biosciences Inc. insider trading activity?

View the latest insider trading data for Tuhura Biosciences Inc. on Alpha Lenz.

What is Tuhura Biosciences Inc.'s P/E ratio?

Tuhura Biosciences Inc.'s P/E ratio is -3.6.

Tuhura Biosciences Inc.

NASDAQ · HURA
$2.23-0.04(-1.76%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Tuhura Biosciences Inc.'s future dividend policy...
Alpha Chat Insight

Tuhura Biosciences Inc. trades at a P/E of -3.6 (undervalued) with modest ROE of -169.2%.

Ask for details

Company Overview

Tuhura Biosciences Inc. is a biotechnology company focused on pioneering advancements in the field of genomic and proteomic research. The primary function of Tuhura Biosciences is to develop and provide cutting-edge solutions for the identification and analysis of complex biological data, which is crucial for understanding disease mechanisms and therapeutic targets. Leveraging state-of-the-art technologies, Tuhura aims to enhance drug discovery and development, impacting sectors such as healthcare, pharmaceuticals, and personalized medicine. Tuhura Biosciences Inc. specializes in the integration of advanced analytics and artificial intelligence to improve the accuracy and efficiency of genomic interpretations. This positions the company at the forefront of precision medicine, enabling more targeted and effective treatments. Given the increasing reliance on biotechnology for innovation in medical therapies, Tuhura's contributions are significant within the market, particularly as the global demand for more personalized healthcare solutions continues to grow. With a focus on improving the intersection of biology and technology, Tuhura Biosciences Inc. plays a crucial role in the ongoing transformation of medical research and patient care.

CEODr. James A. Bianco M.D.
SectorHealthcare
IndustryBiotechnology
Employees19

Company Statistics

FY 2025

Profile

$106.88MMarket Cap
$0.00Revenue
0.00Shares Out
19Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

-3.56P/E
5.11P/B
N/AEV/Sales
-3.84EV/EBITDA
-3.86P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-127.02%ROA
-169.18%ROE
-124.37%ROIC

Financial Health

$3.62MCash & Cash Equivalents
$2.80MNet Debt
30.67%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Tuhura Biosciences Inc. (ticker: HURA) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 19 employees. Market cap is $107M.

The current price is $2.23 with a P/E ratio of -3.56x and P/B of 5.11x.

ROE is -169.18%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Tuhura Biosciences Inc. (HURA) Stock Forecast 2026 $2.23 — Price, Financials & Analyst Targets | Alpha Lenz